found glp 1 GLP-1 medicines entered clinical use in 2005 as treatments for Type 2 diabetes. Over time, doctors observed their effects on appetite and body weight, leading to separate approvals for obesity Ole Miss researchers study barriers

Minoxidil has been the go-to topical treatment since the FDA first approved it in 1988

The resulting payer policy cascade is converting an estimated 750 million previously untreated patients into commercially addressable prescription candidates

Farxiga/Forxiga (dapagliflozin) Disease area(s): Metabolic diseases Manufacturer(s): AstraZeneca 2024 Sales (USD): $7.72 billion Why it sold so well: In 2024, AstraZenecas Farxiga achieved robust sales growth, with revenues increasing by 21% year-over-year to $1.9 billion in the fourth quarter alone and by 28% compared to 2023, making it the companys top seller in 2024

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis